TRIM37 and neoplasm: TRIM37 overexpression renders RAS-transformed, premalignant breast cells tumorigenic, and inhibition of TRIM37 function reduces tumor growth in xenograft and patient-derived mouse models (Bhatnagar et al, 2014).